Pharmaids Pharmaceuticals Ltd
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd manufactures Bulk Drugs and Intermediaries.
- Market Cap ₹ 132 Cr.
- Current Price ₹ 59.0
- High / Low ₹ 79.2 / 27.8
- Stock P/E
- Book Value ₹ 9.60
- Dividend Yield 0.00 %
- ROCE -64.4 %
- ROE -49.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 6.15 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -3.61%
- Promoter holding is low: 5.64%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
3.94 | 0.00 | |
3.81 | 9.89 | |
Operating Profit | 0.13 | -9.89 |
OPM % | 3.30% | |
0.02 | 0.00 | |
Interest | 0.00 | 0.00 |
Depreciation | 0.01 | 0.02 |
Profit before tax | 0.14 | -9.91 |
Tax % | 0.00% | 23.71% |
0.15 | -7.56 | |
EPS in Rs | 0.15 | -3.52 |
Dividend Payout % | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -5140% |
Stock Price CAGR | |
---|---|
10 Years: | 36% |
5 Years: | 66% |
3 Years: | 47% |
1 Year: | 103% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -49% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|
Equity Capital | 10.27 | 21.44 | 21.44 |
Reserves | -1.60 | 0.67 | -0.82 |
0.00 | 0.00 | 0.00 | |
2.44 | 2.48 | 0.24 | |
Total Liabilities | 11.11 | 24.59 | 20.86 |
0.03 | 0.11 | 10.66 | |
CWIP | 0.45 | 2.00 | 2.14 |
Investments | 0.00 | 3.31 | 3.51 |
10.63 | 19.17 | 4.55 | |
Total Assets | 11.11 | 24.59 | 20.86 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
-0.26 | -4.02 | |
0.47 | -4.94 | |
0.00 | 21.31 | |
Net Cash Flow | 0.21 | 12.35 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | |
---|---|---|
Debtor Days | 124.14 | |
Inventory Days | 90.99 | 0.00 |
Days Payable | 236.18 | |
Cash Conversion Cycle | -21.05 | |
Working Capital Days | -17.60 | |
ROCE % | -64.39% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 10 Apr
- Compliance Certificate Under Regulation 7(3) Of SEBI Listing Regulations 2015 For The Year Ended 31St March 2024. 10 Apr
- Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March 2024. 8 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
5 Apr - Certificate under regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended 31st March 2024.
- Closure of Trading Window 28 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Portfolio:
a) Specialty Chemicals:[1] Retinol, DL Alpha Tocopherol, D-Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10, D-Biotin
b) Skin Care:[2] Best care hands, Hands Sanitizer, Moisturizing Cream, Skin-Sure Plus, Skin-Sure Ultra, Alcohol Gel, Barrier Cream
c) Hospital Care:[3] Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen-G, Strumen TRIACID, Facein Eco, Facein Power, Facein Spray, Sod Hypochlorite, Wipes, PPE
d) Generics:[4] Linzomust, Ceforoot 1.5g, Trendyclav-L, Cobasure Gold 2ML INJ, Benfoshine, Amplimmune, Thiaxa T8, Molprime SR, Citibrain-Plus, Duojoint